BASF Personal Care Introduces Encapsulation Technology for Retinol
BASF’s Personal Care business has launched a new ingredient, VitaGuard A, to meet the continued demand for retinol and strengthen its position as a cosmetic staple. This latest innovation is based on the encapsulation of free retinol.
Retinol is a potent anti-aging molecule that is widely used in cosmetics. However, it can also cause skin irritation and is easily degraded by light and air, making it difficult for formulators to use it widely. VitaGuard A has been developed using patented solid lipid particles that prevent retinol degradation, limit skin irritation, and increase skin bioavailability, thereby improving cosmetic results.
Multiple in vitro and ex vivo studies conducted by BASF have shown that VitaGuard A improves the stability of retinol in cosmetic formulations, improves skin bioavailability, and prevents retinol-induced irritation compared to non-encapsulated retinol. In addition, it has been shown to clinically improve the appearance of forehead wrinkles, skin elasticity and skin tone evenness, complementing retinol’s attractive properties as an anti-aging molecule.
2026-07-27
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Multiple Chemical Industry Leaders Post Strong H1 Earnings Growth as Sector Profitability Revives
-
The Crop Protection Patent Cliff Is Here
-
BASF's Intensified Moves from May to June: Plant Closures, Divestitures, and Transformation in Sync
-
EU Clears Carlyle's Acquisition of BASF's Coatings Business, but Demands Divestment of Nouryon's Polysulfide Assets: What Are the Underlying Risks?
-
BASF, Covestro, Huntsman Raise MDI Prices in North America Amid Global Supply Crunch
-
BASF Launches Global Expansion Plan for Aroma Ingredients
-
BASF Launches Global Expansion Plan for Aroma Ingredients
-
BASF’s €8.7 Billion Zhanjiang Verbund Site Fully Operational
-
BASF and Hannong Chemical Joint Venture Nonionic Surfactant Plant Begins Operation in South Korea
-
BASF Battles Market Turmoil as Profits Slide
Recommend Reading
-
Unable to Buy Entire AkzoNobel, Nippon Paint Begins a "Disassembled Approach"
-
After Two Price Hikes in One Week, Dow Has Fully Exposed the Most Sensitive Nerve in Europe’s Polyurethane Market
-
Wanhua Chemical's Hungarian 650,000-ton MDI/TDI Plant to Shut Down for 35-Day Maintenance
-
“Europe’s Chemical Industry Is Bleeding”: 37 Million Tons of Capacity Shut Down in 4 Years—Is the Industrial Heartbeat Failing?
-
“Amputate to Survive, or Bleed to Feed the Vultures?”: Dow’s 4,500 Layoffs Reveal the Life-or-Death Battle in Global Chemicals
-
Insufficient Downstream Demand Puts Pressure on DMF Market
-
关于将4-amino-1-boc-piperidine、tert-buty 4-aminopiperidine-1-carboxylate产品列入《ECHEMI平台禁限售商品目录》的公告 Announcement on Including 4-amino-1-boc-piperidine and tert-buty 4-aminopiperidine-1-carboxylate in the Announcement on the List of Prohibited Sales of Prohibited and Controlled Items on ECHEMI
-
Methanol Market Partially Rises
-
Cyclohexane Market Supply and Demand Balance, Prices Remain Stable
-
After Two Rounds of Price Cuts, the Coke Market Stabilizes in China